Skip to main content
PLOS One logoLink to PLOS One
. 2025 Apr 17;20(4):e0321176. doi: 10.1371/journal.pone.0321176

A protocol for a systematic review and meta-analysis of the effect of muscle energy techniques on shoulder joint pain

Ye Ji Kim 1,*,#, Seojae Jeon 2,*,#, Hyeonjun Woo 3, Won-Bae Ha 4, Junghan Lee 4
Editor: Seyed Hamed Mousavi5
PMCID: PMC12005804  PMID: 40245368

Abstract

Introduction

Muscle energy techniques (MET) for shoulder muscles improve both shoulder muscle tension and the range of motion of the glenohumeral joint. This systematic literature review will investigate the effects of MET on shoulder pain as a result of muscle tension in the glenohumeral joints of patients with shoulder disorders and collect clinical evidence regarding the effectiveness of muscle energy techniques on glenohumeral joint pain. Based on previous studies, we anticipate that MET may significantly affect shoulder joint pain. We expect to provide moderate to high levels of evidence regarding the effectiveness of MET in the treatment of shoulder pain.

Methods

Nine electronic databases will be searched for articles published up to November 2024, including PubMed, EMBASE, CENTRAL, KCI, KISS, KMbase, RISS, DBpia, and OASIS. Search terms will consist of terms related to the outcome (e.g., “shoulder”) and intervention (e.g., “muscle energy technique,” “post-isometric relaxation,” “isometric stretching”). Studies selected for the systematic review and meta-analysis will include randomized controlled clinical trials and studies using MET applied to the human shoulder muscles. Qualitative and case studies will be excluded. Two authors will independently assess each study for eligibility and risk of bias and extract the data. This study will analyze the effects of MET on shoulder pain. Additionally, we intend to demonstrate the effect size of muscle energy techniques on factors such as range of motion. Our study will provide clinical evidence for the effects of muscle energy techniques on shoulder joint pain. Our study aims to provide clinical evidence supporting the moderate-to-high effectiveness of MET in treating shoulder joint pain.

Prospero registration

ClinicalTrials.gov CRD42024532367

Introduction

The shoulder complex consists of four joints, the acromioclavicular, sternoclavicular, glenohumeral, and scapulothoracic joints, formed by articulation of the clavicle, scapula, ribs, humerus, and surrounding soft tissues such as muscles and ligaments. These structures produce highly coordinated movement across multiple joints. The shoulder complex prioritizes mobility over stability and offers the greatest range of motion (ROM) among the joints of the human body. Consequently, due to its anatomical instability, it is prone to pain and dysfunction [1].

The disruption or weakness of any muscle in this region can impede the inherent continuum of motion, resulting in pain [2]. Therefore, when considering shoulder pathology from a functional perspective, the entire shoulder complex must be investigated to restore muscle balance. Currently, surgical interventions dominate the treatment of shoulder disorders. However, these surgeries often lead to secondary complications, including stiffness and arthrofibrosis [3,4].

One method for minimizing surgical side effects, alleviating pain, and enhancing functional movement is the muscle energy technique (MET) [5,6]. The MET aims to reduce pain and improve restricted joint mobility [7]. Its mechanism involves post-isometric relaxation and reciprocal inhibition following muscle contraction. Muscle and joint tension decrease within approximately 15 s of isometric contraction, thus facilitating the natural expansion of joint movement [8]. Additionally, muscles treated with MET exhibit increased elasticity, whereas the joint capsule and surrounding tissue may elongate. Consequently, the elasticity and structure of the muscles and tissues change, ultimately increasing the joint range of motion and alleviating shoulder joint pain. Furthermore, MET-induced joint movements enhance proprioceptive feedback and improve motor control and learning abilities [9].

Because of these advantages, the MET is widely used in clinical settings, particularly in patients with adhesive capsulitis and upper crossed syndrome. Randomized controlled trials (RCTs) have been conducted on MET [10,11]. However, studies analyzing the effects of the shoulder joint MET on pain and ROM in all patients are lacking. Although numerous studies have analyzed the effects of massage, shoulder joint mobilization, manual therapy such as the Kaltenborn mobilization and Mulligan techniques, and stretching exercises on shoulder ROM and pain, no independent study has analyzed the effects of MET alone on shoulder joint pain and ROM [1215]. Therefore, this study aims to analyze the effect size of MET techniques on shoulder joint pain and function through a systematic literature review and meta-analysis to comprehensively consolidate previous research findings.

Methods

Registration of this study

The proposed systematic review was formally registered with the International Prospective Register of Systematic Reviews (PROSPERO) under the registration number CRD42024532367 on May 5, 2024. This study will involve a systematic review and update according to this protocol. This protocol strictly adheres to the guidelines outlined in the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols 2015 statement [16] as well as the Cochrane Handbook for Systematic Reviews of Interventions [17]. Any modifications to previously published protocols will be explicitly noted, accompanied by a thorough delineation of the amendments.

Data sources

Two independent researchers (YJK and SJJ) will comprehensively search nine databases from their inception up to November 2024. The study will encompass three English-language databases: MEDLINE via PubMed, EMBASE via Elsevier, and the Cochrane Central Register of Controlled Trials CENTRAL), and six Korean-language databases: Korea Citation Index (KCI), Korean Studies Information Service System (KISS), Korean Medical Database (KMbase), Research Information Service System (RISS), Data Base Periodical Information Academic (DBpia), and Oriental Medicine Advanced Searching Integrated System (OASIS). In addition, we will explore the reference lists of pertinent articles and conduct manual inquiries using Google Scholar to identify further contributions. Our search will encompass both peer-reviewed journal literature and “gray literature” such as theses and conference proceedings.

Search strategies

The search terms will comprise the disease term (e.g., “shoulder impingement syndrome” and “rotator cuff tear”) and intervention term (e.g., “muscle energy technique on shoulder”). Table 1 shows the search strategies for the PubMed and EMBASE databases, which will be modified and used similarly for other databases.

Table 1. Search strategy according to PICO.

Criteria Standard contents
Research method Randomized controlled clinical trials
Research design Randomized controlled clinical trials
Purpose Research purposes will be revealed.
Participants/Patients Patients with shoulder movement problems. No restriction will be placed on the sex, race, or age of the participants.
Intervention/Moderate variables Muscle energy technique applied to the human shoulder muscles
Comparison Placebo and blank control
Outcomes -Primary Outcomes
Visual Analogue Scale
-Secondary Outcomes
Range of motion of shoulder joint
Shoulder pain and disability index
Quality of life
Data statistics All figures depicting mean, standard deviation, and t and f values, to calculate effect size

Inclusion criteria

RCTs will be included in this systematic review and meta-analysis. Qualitative studies and case studies will be excluded from the analysis.

We will include studies of patients with shoulder pain attributed to shoulder joint disorders without restrictions on sex, age, or race. Studies using METs applied to human shoulder muscles will be included with no restrictions on comparator conditions (no treatment, stretching, or other manipulations).

Types of outcome measures

Primary outcome.

The primary outcome measure will be the visual analog scale (VAS) score developed by Hayes and Patterson in 1921, which is used to subjectively evaluate acute and chronic pain, similar to other assessment tools used to evaluate shoulder joint pain in each study. Scores are documented by marking a 10-cm line, symbolizing a spectrum from “no pain” to “worst pain,” through handwritten notations adhering to academic conventions [18].

Secondary outcome.

Tools for evaluating range of motion (ROM) and function related to the shoulder joint will be employed to assess the secondary outcomes.

  • 1)

    The ROM of the shoulder joint measured using a universal goniometer will be included as a secondary outcome, focusing on the effect on daily activities, including flexion, extension, and abduction of the shoulder joint [19].

  • 2)

    Roach et al. developed the shoulder pain and disability index (SPADI), a self-administered questionnaire consisting of 13 items, to measure shoulder pain and disability [20]. The questions are classified into two subscales: a 5-item subscale that measures pain and an 8-item subscale that measures disability. The SPADI has two versions: one is scored on a VAS and the other is scored on a numerical rating scale (NRS). Each subscale is totaled and converted to a score of 100. The average of the two subscales is calculated to obtain a total score of 100, with higher scores indicating greater impairment or disability [21].

  • 3)

    Quality of life (QOL) is defined as “An individual’s perception of their position in life in the context of the culture in which they live and in relation to their goals, expectations, standards, and concerns” [22]. QOL is an important consideration for improving the symptom relief, care, and rehabilitation of patients [23].

  • 4)

    Disabilities of the Arm, Shoulder and Hand (DASH)

is a self-administered questionnaire designed to measure physical function and symptoms in individuals with musculoskeletal disorders of the upper limb. It comprises 30 items that assess the impact of arm, shoulder, and hand impairments on daily activities, work, and recreational tasks. Each item is rated on a 5-point Likert scale, and the overall score is calculated and transformed to a scale ranging from 0 (no disability) to 100 (most severe disability). The DASH has been widely validated and is recognized for its reliability in clinical research and practice [24].

  • 5)

    Global Rating of Change (GROC) Scale

is a single-item, patient-reported outcome measure used to capture an individual’s overall perception of change in their condition following an intervention. Patients are asked to rate their change relative to baseline on a scale that typically ranges from –7 (a very great deal worse) to + 7 (a very great deal better), with 0 indicating no change. This scale provides a comprehensive overview of treatment effectiveness by reflecting perceived improvements or deteriorations in pain, function, and quality of life [25].

Study selection

Two independent researchers (YJK and SJJ) will oversee the study selection process while adhering to the outlined criteria (Table 1). After eliminating duplicate entries, YJK and SJJ will scrutinize the titles and abstracts of the retrieved studies to determine their relevance, and thoroughly evaluate the full texts of the selected studies for eligibility. Any disagreements regarding the study selection will be resolved through consultation with other researchers. Our approach to literature selection will be documented in accordance with the PRISMA guidelines (Fig 1) [26].

Fig 1. PRISMA-compliant flow diagram depicting selection of studies.

Fig 1

Data extraction

Data extracted will encompass the primary author’s name, publication year, country of origin, paper title, sample size, dropout count, participants’ age and sex, intervention and comparison specifics, adverse effects of the intervention, research design, measurement tools employed and independent, dependent, mediated, and control variables as well as subfactors pertinent to shoulder joint pain.

Specifically, for data collection on intervention outcomes, in order to comprehensively understand the durability of the effects of MET, data on pain, joint range of motion, and quality of life will be collected at time points such as 3 months, 6 months, or even 1 year after treatment.

For instance, upon confirming that a study used METs or similar interventions, we will focus on quantifying the degree of improvement observed in shoulder joint pain based on the primary outcome measure. Subsequent considerations will include variables such as shoulder mobility and functional activity. Furthermore, studies that compare techniques, such as the Mulligan or Kaltenborn mobilization techniques, with METs, will be categorized and comparatively analyzed to assess their efficacy.

The compiled data will be systematically recorded using Excel 2024 (Microsoft, Redmond, WA, USA) and shared with the researchers using Dropbox folders (Dropbox Inc., San Francisco, CA, USA). If the data are deemed insufficient or ambiguous, correspondence with the respective authors of the included studies will be initiated via email to request supplementary information.

Quality assessment

Two independent researchers (YJK and SJJ) will evaluate the methodological quality of the included studies and the quality of evidence of each primary finding. Discrepancies will be resolved through consultation with other researchers. The methodological quality of the studies will be assessed using the Cochrane risk-of-bias tool [27]. Random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessments, incomplete outcome data, selective reporting, and other biases will be assessed in each study. Each domain will be categorized as “low risk,” “unclear,” or “high risk.” The evaluation results will be documented in an Excel 2024 spreadsheet and shared among the researchers using Dropbox.

The assessed outcomes will be comprehensively presented in a full review using ReviewManager version 5.3 (Cochrane, London, UK). The quality of the evidence will be depicted through a summary of the findings. The evaluation procedure will be shared and discussed among researchers.

Data synthesis and analysis

ReviewManager version 5.3 and Excel 2024 will be used for data synthesis and analysis. Researchers will collaborate using Dropbox folders to share files. Descriptive analyses of participant demographics, interventions, and outcomes will be conducted for all included studies. Studies involving comparable interventions, comparisons, and outcomes will be quantitatively synthesized. Data will be analyzed in two phases: (1) data synthesis and analysis after the systematic review process and (2) categorization of studies with figures suitable for meta-analysis.

The first step is a systematic review to comprehensively organize and analyze studies that show significant effects of METs on shoulder pain among patients. Each study will be classified and coded to “author (year of publication),” “participants (patients),” “difference in shoulder pain before and after muscle energy technique,” “research methods,” “research procedures,” and “research result.” Second, the effects of METs on shoulder joint pain described in the selected papers will be systematized through discussions and reviews among the researchers.

To assess the correlation between shoulder pain and the MET score in each study, we will designate and code the analyzed items as follows: First, we will categorize and compare outcomes based on the techniques applied to patients with shoulder pain, while distinguishing MET from other techniques as variables. Second, in studies using only the MET, we will define MET application and non-application groups as variables and compare the differences in outcomes. Third, in studies examining the application of the MET in patients with shoulder joint pain, we will identify correlation codes, review theoretical backgrounds, classify each variable into an analyzable framework, and synthesize sub-variables. Subsequently, we will analyze the overall publication bias, verify homogeneity, analyze the overall effect size, and investigate the correlation effect size among all factors related to the rehabilitation period. The size of the correlation effects will be analyzed using Fisher’s z value [28] (0.1 =  small effect size, 0.3 =  medium effect size, and 0.5 =  large effect size) by calculating the correlation coefficient with a 95% confidence interval. We will evaluate the heterogeneity among the studies using both the chi-square test and the I-squared statistic. I-squared values >  50% and >  75% will be considered indicative of substantial and high heterogeneity, respectively. A random-effects model will be applied when significant heterogeneity is detected (I-squared value >  75%), whereas a fixed-effects model will be employed when heterogeneity is not significant, or if the number of studies included in the meta-analysis is very small and inter-study variance estimates lack precision. [29] If heterogeneity is deemed too substantial for synthesis (I-squared value >  75%), a subgroup analysis will be conducted to elucidate the source of heterogeneity.

Assessing the quality of the body of evidence

The quality of evidence will be evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) [30] framework across five categories: risk of bias, imprecision, inconsistency, indirectness, and other factors such as publication bias.

Subgroup analysis

If heterogeneity is significant (I-squared value >  75%) and the necessary data are available, we will perform a subgroup analysis to account for heterogeneity. We will also conduct a subgroup analysis for the following potential factors: age, sex, race, session duration, different levels and types of joint mobilization, and other factors that may affect the results.

Sensitivity analysis

To assess the robustness of the meta-analysis results, sensitivity analyses will be conducted by excluding 1) studies with a high risk of bias, 2) studies with missing data, and 3) outliers.

Assessment of reporting bias

If the analysis includes more than 10 trials, reporting biases, including publication bias, will be assessed using funnel plots and the trim-and-fill method. If asymmetry is observed in the funnel plots, indicating a potential reporting bias, further investigation will be conducted to identify the possible causes of the asymmetry.

Ethics and dissemination

Ethical approval is unnecessary as individual patient data will not be included in this systematic review. The findings will be shared through publication of the manuscript in a peer-reviewed journal and/or presentation at a pertinent conference.

Discussion

The primary treatment goals of rehabilitation therapy are pain relief and ROM restoration. Particularly in the shoulder joint, which demands a wide ROM and is predominantly utilized in daily activities, pain and limited ROM can significantly affect an individual’s functional performance, making rehabilitation therapy a major focus in clinical practice [31]. Shoulder pain in patients with shoulder disorders reduces shoulder ROM, thereby compromising QOL [32]. Therefore, establishing effective treatment interventions is crucial for shoulder joint pain rehabilitation. MET is broadly applicable to various musculoskeletal conditions, with relatively immediate and sustained effects and minimal patient discomfort [33,34]. Therefore, it is considered useful for reducing muscle tension, improving pain, and restoring joint ROM. However, to date, no systematic literature review has been conducted on the effects of the MET on shoulder joint pain and function. This study aims to analyze the effect size of the MET on shoulder joint pain and its contribution to shoulder joint mobility, function, and improvement in patients’ quality of life. We believe that the results of this systematic review will provide clinical evidence for the use of the MET in treating restricted shoulder joint mobility. Furthermore, by proposing effective methods for shoulder rehabilitation, we hope to offer valuable and cost-effective alternatives for the healthcare sector. This systematic review and meta-analysis will have several limitations. First, significant heterogeneity is anticipated among the included RCTs. Variations in participant inclusion criteria, intervention protocols, assessment tools, and follow-up duration across studies may influence the overall interpretation of the findings. To address this, subgroup analyses using consistent criteria will be conducted to minimize heterogeneity. Second, there is a considerable risk of bias. Although the quality of the included studies will be assessed using the Cochrane RoB 2.0, the studies may not have been methodologically robust in terms of design or execution. Third, the use of diverse outcome assessment methods across the studies presents some challenges. Differences in follow-up periods and tools used to evaluate outcomes such as pain and functional recovery may complicate the aggregation of the results. To mitigate this issue, we will standardize the outcome measures or utilize statistical methods that allow for the integration of diverse outcomes. Fourth, the small sample sizes of some RCTs may lead to inadequate statistical power. Smaller studies are more prone to random errors, which could adversely affect the reliability of meta-analysis results. To compensate for this, wider confidence intervals will be used. Considering these limitations, caution is advised when interpreting the findings of this review, and larger-scale RCTs are required in future research to strengthen the evidence base.

Supporting information

S1 Appendix. Search terms and strategies.

(DOCX)

pone.0321176.s001.docx (17.1KB, docx)
S1 Checklist. PRISMA-P Checklist.

(PDF)

pone.0321176.s002.pdf (40.6KB, pdf)

Acknowledgments

The authors have no acknowledgments to declare.

Data Availability

Deidentified research data will be made publicly available when the study is completed and published.

Funding Statement

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: RS-2023-KH142004).

References

  • 1.Williams PL. Gray’s anatomy (The anatomical basis of medicine and surgery). Edinburgh: Churchill Livingstone; 1995. [Google Scholar]
  • 2.Da N. Kinesiology of the musculoskeletal system: Foundations for rehabilitation. Amsterdam: Elsevier; 2018. [Google Scholar]
  • 3.Shin JJ, Popchak AJ, Musahl V, Irrgang JJ, Lin A. Complications after arthroscopic shoulder surgery: A review of the American board of orthopaedic surgery database. J Am Acad Orthop Surg Glob Res Rev. 2018;2(12):e093. doi: 10.5435/JAAOSGlobal-D-18-00093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Koorevaar RCT, Van’t Riet E, Ipskamp M, Bulstra SK. Incidence and prognostic factors for postoperative frozen shoulder after shoulder surgery: a prospective cohort study. Arch Orthop Trauma Surg. 2017;137(3):293–301. doi: 10.1007/s00402-016-2589-3 [DOI] [PubMed] [Google Scholar]
  • 5.Patil PP, Kadam DN. Effectiveness of muscle energy technique on shoulder range of motion in individuals with bicipital tendinitis, randomised clinical trial. Int J Phys Educ Sports Health. 2022;9(4):163–7. doi: 10.22271/kheljournal.2022.v9.i4c.2588 [DOI] [Google Scholar]
  • 6.Paul S, Ghosh T. Effects of muscle energy technique on improving the range of motion and pain in patients with frozen shoulder. Biomedicine. 2023;43(1):26–9. doi: 10.51248/.v43i1.2566 [DOI] [Google Scholar]
  • 7.Thomas E, Cavallaro AR, Mani D, Bianco A, Palma A. The efficacy of muscle energy techniques in symptomatic and asymptomatic subjects: A systematic review. Chiropr Man Therap. 2019;27:35. doi: 10.1186/s12998-019-0258-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chaitow L, Crenshaw K. Muscle energy techniques. Amsterdam: Elsevier Health Sciences; 2006. [Google Scholar]
  • 9.Fryer G. Muscle energy technique: An evidence-informed approach. Int J Osteopathic Med. 2011;14(1):3–9. [Google Scholar]
  • 10.Iqbal M, Riaz H, Ghous M, Masood K. Comparison of Spencer muscle energy technique and Passive stretching in adhesive capsulitis: A single blind randomized control trial. J Pak Med Assoc. 2020;70(12(A)):2113–8. [DOI] [PubMed] [Google Scholar]
  • 11.Thomas A, D’Silva C, Mohandas L, Pais SMJ, Samuel SR. Effect of muscle energy techniques v/s Active range of motion exercises on shoulder function post modified radical neck dissection in patients with head and neck cancer - A Randomized Clinical Trial. Asian Pac J Cancer Prev. 2020;21(8):2389–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yeun Y-R. Effectiveness of massage therapy on the range of motion of the shoulder: A systematic review and meta-analysis. J Phys Ther Sci. 2017;29(2):365–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zavala-González J, Pavez-Baeza F, Gutiérrez-Espinoza H, Olguín-Huerta C. The effectiveness of joint mobilization techniques for range of motion in adult patients with primary adhesive capsulitis of the shoulder: A systematic review and meta-analysis. Medwave. 2018;18(5):e7500. [DOI] [PubMed] [Google Scholar]
  • 14.Ishaq H, Zuber M, Kandakurti PK, Arulsingh W. Do manual therapy techniques help in patients with frozen shoulder? A systematic literature review. 2022;34(2):1–28.
  • 15.Tauqeer S, Arooj A, Shakeel H. Effects of manual therapy in addition to stretching and strengthening exercises to improve scapular range of motion, functional capacity and pain in patients with shoulder impingement syndrome: A randomized controlled trial. BMC Musculoskelet Disord. 2024;25(1):192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ. 2015;350:g7647. [DOI] [PubMed] [Google Scholar]
  • 17.Higgins JT, Chandler J, Cumpston M, Li T, Page M, Welch V. Cochrane handbook for systematic reviews of interventions version 6.4. 2023. Available from: www.training.cochrane.org/handbook [Google Scholar]
  • 18.Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR, et al. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev. 2018;2(3):e088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lea RD, Gerhardt JJ. Range-of-motion measurements. J Bone Joint Surg Am. 1995;77(5):784–98. [DOI] [PubMed] [Google Scholar]
  • 20.Roach KE, Budiman-Mak E, Songsiridej N, Lertratanakul Y. Development of a shoulder pain and disability index. Arthritis Care Res. 1991;4(4):143–9. doi: 10.1002/art.1790040403 [DOI] [PubMed] [Google Scholar]
  • 21.Breckenridge JD, McAuley JH. Shoulder pain and disability index (SPADI). J Physiother. 2011;57(3):197. doi: 10.1016/S1836-9553(11)70045-5 [DOI] [PubMed] [Google Scholar]
  • 22.The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–9. [DOI] [PubMed] [Google Scholar]
  • 23.Haraldstad K, Wahl A, Andenæs R, Andersen JR, Andersen MH, Beisland E, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 2019;28(10):2641–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Roy J-S, MacDermid JC, Woodhouse LJ. Measuring shoulder function: A systematic review of four questionnaires. Arthritis Rheum. 2009;61(5):623–32. [DOI] [PubMed] [Google Scholar]
  • 26.Bobos P, Ziebart C, Furtado R, Lu Z, MacDermid JC. Psychometric properties of the global rating of change scales in patients with low back pain, upper and lower extremity disorders. A systematic review with meta-analysis. J Orthop. 2020;21:40–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. [DOI] [PubMed] [Google Scholar]
  • 28.Borenstein M. Effect sizes for continuous data. In: Cooper H, Hedges LV, Valentine JC, Editors. The handbook of research synthesis and meta-analysis, 2nd ed. New York, NY, US: Russell Sage Foundation; 2009. p. 221–35. [Google Scholar]
  • 29.Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111. [DOI] [PubMed] [Google Scholar]
  • 30.Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6. [DOI] [PubMed] [Google Scholar]
  • 31.Davis DL, Almardawi R, Beamer BA, Ryan AS, Terrin ML. Shoulder pain, health-related quality of life and physical function in community-dwelling older adults. Front Aging. 2023;4:1176706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Özden F, Tuğay N, Karaman ÖN, Kilinç CY, Tuğay BU. The relationship of fear of movement with pain, range of motion and function in patients with shoulder pathologies. Bull Fac Phys Ther. 2021;26(1). [Google Scholar]
  • 33.Al Matif S, Alfageer G, ALNasser N, Alabbas G, Al Sawidan H, ALhareth H. Effectiveness of muscle energy technique on pain intensity and disability in chronic low back patients: A systematic review. Bull Fac Phys Ther. 2023;28(1). [Google Scholar]
  • 34.Santos GK, Gonçalves de Oliveira R, Campos de Oliveira L, Ferreira de Oliveira C, Andraus RA, Ngomo S, et al. Effectiveness of muscle energy technique in patients with nonspecific low back pain: A systematic review with meta-analysis. Eur J Phys Rehabil Med. 2022;58(6):827–37. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Mohammadreza Pourahmadi

13 Aug 2024

PONE-D-24-23377A protocol for a systematic review and meta-analysis of the effect of muscle energy techniques on shoulder joint painPLOS ONE

Dear Dr. Jeon,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

The authors should enhance the methodology of their systematic review protocol by including specific search strategies for each database to be utilized, employing a valid risk of bias assessment tool, and detailing the methods for conducting the meta-analysis.

==============================

Please submit your revised manuscript by Sep 27 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Mohammadreza Pourahmadi, PT, Ph.D., Postdoctoral Fellow

Academic Editor

PLOS ONE

Journal requirements:   

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

Additional Editor Comments:

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors present a systematic review protocol to collect clinical evidence regarding the effectiveness of muscle

energy techniques on glenohumeral joint pain.

Some suggestions for the manuscript to be revised:

Introduction:

After the sentence, "Randomized controlled trials (RCTs) have been conducted on METs.", authors must include two references of RCTs published in the last 10 years at least.

Methods:

I suggest that the authors change this to: Studies selected for systematic review and meta-analysis will include randomized controlled clinical trials and quasi-randomized controlled trials, avoiding the inclusion of non-randomized and observational studies. In line 132, just leave "The systematic review and meta-analysis will include RCTs and quasi-randomized controlled trials."

On line 154, cite a reference that talks about ROM. In line 196, you must insert the reference to the Cochrane Rob2.0 tool.

Discussion:

The authors must introduce a paragraph with the possible limitations of the future review, such as high heterogeneity between RCTs, high risk of bias, different ways of evaluating outcomes in trials, such as follow-up time, instruments used and small number of patients in RCTs compromising the quality of the results.

Reviewer #2: 1. Please provide a search strategy for each database.

2. You mentioned that a variety of research types will be included, including: randomized controlled clinical trials, quasi-randomized controlled trials, and controlled (non-randomized) clinical trials. However, the inclusion of multiple studies will lead to increased heterogeneity. How to deal with it?

3. It is unclear whether the study follows the PICOS framework.

4. Cochrane Collaboration's risk-of-bias tool is for RCTs. How do non-randomized controlled trials assess quality? You didn't provide further details.

5.The protocol suggests utilizing funnel plots to evaluate publication bias; however, this technique may have its drawbacks. Incorporating other methods, such as the trim-and-fill method or cumulative meta-analysis, could yield more reliable insights regarding publication bias. A thorough evaluation of publication bias is essential to guarantee the dependability of the meta-analysis results.

6. Limitations of this study should be added to the discussion section.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Ricardo Ney Cobucci

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Apr 17;20(4):e0321176. doi: 10.1371/journal.pone.0321176.r003

Author response to Decision Letter 1


3 Oct 2024

Reviewer #1: The authors present a systematic review protocol to collect clinical evidence regarding the effectiveness of muscle energy techniques on glenohumeral joint pain.

Some suggestions for the manuscript to be revised:

Introduction:

After the sentence, "Randomized controlled trials (RCTs) have been conducted on METs.", authors must include two references of RCTs published in the last 10 years at least.

- I added references.

Methods:

I suggest that the authors change this to: Studies selected for systematic review and meta-analysis will include randomized controlled clinical trials and quasi-randomized controlled trials, avoiding the inclusion of non-randomized and observational studies. In line 132, just leave "The systematic review and meta-analysis will include RCTs and quasi-randomized controlled trials."

- I changed it.

On line 154, cite a reference that talks about ROM. In line 196, you must insert the reference to the Cochrane Rob2.0 tool.

- I added references.

Discussion:

The authors must introduce a paragraph with the possible limitations of the future review, such as high heterogeneity between RCTs, high risk of bias, different ways of evaluating outcomes in trials, such as follow-up time, instruments used and small number of patients in RCTs compromising the quality of the results.

- I added possible limitations on discussion part.

Reviewer #2: 1. Please provide a search strategy for each database.

- I added it with Supporting information (Appendix)

2. You mentioned that a variety of research types will be included, including: randomized controlled clinical trials, quasi-randomized controlled trials, and controlled (non-randomized) clinical trials. However, the inclusion of multiple studies will lead to increased heterogeneity. How to deal with it?

- I excluded controlled (non-randomized) clinical trials.

3. It is unclear whether the study follows the PICOS framework.

- I added it with table.

4. Cochrane Collaboration's risk-of-bias tool is for RCTs. How do non-randomized controlled trials assess quality? You didn't provide further details.

- I added it.

5.The protocol suggests utilizing funnel plots to evaluate publication bias; however, this technique may have its drawbacks. Incorporating other methods, such as the trim-and-fill method or cumulative meta-analysis, could yield more reliable insights regarding publication bias. A thorough evaluation of publication bias is essential to guarantee the dependability of the meta-analysis results.

- I added trim and fill.

6. Limitations of this study should be added to the discussion section.

- I added some limitations in discussion part.

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Decision Letter 1

Mohammadreza Pourahmadi

26 Oct 2024

PONE-D-24-23377R1A protocol for a systematic review and meta-analysis of the effect of muscle energy techniques on shoulder joint painPLOS ONE

Dear Dr. Jeon,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

After reviewing the revised manuscript, the reviewers still had several minor comments, particularly concerning typographical errors and some aspects of the study's methods.

==============================

Please submit your revised manuscript by Dec 10 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Mohammadreza Pourahmadi, PT, Ph.D., Postdoctoral Fellow

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have met most of the recommendations, but there are still flaws in the revised manuscript.

"Studies selected for systematic review and meta-analysis will include randomized controlled clinical trials, quasi-randomized controlled trials, and controlled (nonrandomized) clinical trials" in lines 61 and 62 needs to be corrected, as well as the text in Table 1 Research method Randomized controlled clinical trials, quasi-randomized controlled trials, nonrandomized controlled clinical trials (except for qualitative research and case studies).

Improve the new text of the inclusion and exclusion criteria in lines 134 and 135.

Finally, there are word errors throughout the manuscript and the quality of the scientific writing needs to be improved, with the suggestion that the entire text be reviewed by a native speaker, or a professional language editing service.

Reviewer #2: The paper conducts research on the impact of muscle energy techniques on shoulder joint pain. The research objective is clear and the methods are detailed. The authors have also made good revisions. However, there are still some issues that need to be addressed, which are as follows:

1. The "point" in the subtitle "Effect of muscle energy techniques on shoulder point pain: a protocol" may be a typo of "joint".

2. You said you no longer included non-randomized clinical trials, but you didn't delete "controlled (non-randomized) clinical trials" from the methods section of your ABSTRACT.

3. Appropriate simple descriptions of the expected research results can be added in the abstract, such as what level of evidence support is expected to be provided for the application of MET techniques in the treatment of shoulder joint pain through the research.

4. Now it is October 2024, and it is not appropriate for "comprehensively search the following databases from their inception up to April 2024", please modify it.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Ricardo Ney Cobucci

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Apr 17;20(4):e0321176. doi: 10.1371/journal.pone.0321176.r005

Author response to Decision Letter 2


11 Nov 2024

Response to Reviewers

Dear Editor and Reviewers,

We sincerely appreciate the valuable comments and suggestions provided by the reviewers, which have significantly helped us to improve the quality of our manuscript. We have addressed each of the reviewers’ comments in detail below. Furthermore, we would like to inform you that the entire manuscript has been professionally edited by Editage, a reputable language editing service, to ensure clarity and accuracy in English language usage. We have also received an official certificate from Editage to verify this process, which we are prepared to submit if required.

Response to Reviewer #1

Comment 1: “Studies selected for systematic review and meta-analysis will include randomized controlled clinical trials, quasi-randomized controlled trials, and controlled (nonrandomized) clinical trials” (lines 61 and 62) needs to be corrected, as well as the text in Table 1 (Research method: Randomized controlled clinical trials, quasi-randomized controlled trials, nonrandomized controlled clinical trials, except for qualitative research and case studies).

Response: We have made the requested corrections to the text in both lines 61-62 and Table 1. In the revised manuscript, we have clarified that only randomized controlled trials will be included, as per the latest inclusion criteria. Non-randomized controlled trials have been excluded from our review criteria to ensure methodological rigor.

Comment 2: Improve the new text of the inclusion and exclusion criteria in lines 134 and 135.

Response: We have refined the wording of the inclusion and exclusion criteria in lines 134 and 135 to enhance clarity and precision. The updated criteria explicitly describe the type of studies included and excluded to align with our study objectives and methodology.

Comment 3: There are word errors throughout the manuscript, and the quality of the scientific writing needs to be improved. It is suggested that the entire text be reviewed by a native speaker or a professional language editing service.

Response: We acknowledge this suggestion and have had the entire manuscript professionally edited by Editage. This editing process has corrected any language errors and improved the overall quality of scientific writing. As mentioned, we have received a certificate from Editage confirming the completion of this professional editing service.

Response to Reviewer #2

Comment 1: The "point" in the subtitle "Effect of muscle energy techniques on shoulder point pain: a protocol" may be a typo of "joint."

Response: We apologize for this oversight. We have corrected the subtitle to "Effect of muscle energy techniques on shoulder joint pain: a protocol."

Comment 2: You said you no longer included non-randomized clinical trials, but you didn't delete "controlled (non-randomized) clinical trials" from the methods section of your ABSTRACT.

Response: Thank you for pointing this out. We have revised the methods section of the abstract to exclude any mention of non-randomized clinical trials, aligning it with the revised inclusion criteria.

Comment 3: Appropriate simple descriptions of the expected research results can be added in the abstract, such as what level of evidence support is expected to be provided for the application of MET techniques in the treatment of shoulder joint pain through the research.

Response: We appreciate this suggestion. We have added a brief description in the abstract regarding the anticipated impact of our study, specifically mentioning the potential contribution of evidence supporting the use of MET techniques in treating shoulder joint pain.

Comment 4: Now it is October 2024, and it is not appropriate for "comprehensively search the following databases from their inception up to April 2024". Please modify it.

Response: This has been updated to reflect the current time frame, with the revised text stating that the search will be conducted up to October 2024.

We hope that the revisions and explanations provided here satisfactorily address all the comments and suggestions from the reviewers. We appreciate the opportunity to improve our manuscript and thank the reviewers again for their constructive feedback.

Best regards,

Ye Ji Kim

Attachment

Submitted filename: Response to Reviewers.docx

pone.0321176.s005.docx (17.3KB, docx)

Decision Letter 2

Seyed Hamed Mousavi

15 Jan 2025

PONE-D-24-23377R2A protocol for a systematic review and meta-analysis of the effect of muscle energy techniques on shoulder joint painPLOS ONE

Dear Dr. Jeon,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Dear Authors,

Thank you for your efforts in revising the manuscript in accordance with the reviewers’ comments. Reviewer 2 has highlighted a point that requires further improvement in the manuscript. Please revise the manuscript accordingly and resubmit it.

==============================

Please submit your revised manuscript by Mar 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Seyed Hamed Mousavi

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors met most of the reviewers' recommendations and the manuscript can be accepted. Congratulations

Reviewer #2: The article has been revised very well. Thank you for your efforts. There is still one point that needs to be improved.

Supplement of Long-term Follow-up and Safety Assessment: The current research protocol mainly focuses on the short-term efficacy of MET on shoulder joint pain and function, but lacks consideration of its long-term effects. A plan for long-term follow-up of patients should be added. For example, the indicators such as pain, range of motion of the joint, and quality of life should be evaluated at 3 months, 6 months, or even 1 year after treatment to comprehensively understand the durability of the efficacy of MET. At the same time, the safety assessment during the MET treatment process is not involved in the article. Observation indicators and methods should be supplemented to record possible adverse reactions (such as muscle strains, excessive joint movement, etc.) to ensure the safety of this treatment method in clinical application.

Reviewer #3: Following the review of the author’s reply to the concerns that were raised previously, I recommend approval of the article for publication. Thank you

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Ricardo Ney Cobucci

Reviewer #2: No

Reviewer #3: Yes:  Collins Ogbeivor

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Apr 17;20(4):e0321176. doi: 10.1371/journal.pone.0321176.r007

Author response to Decision Letter 3


25 Feb 2025

Thank you for reviewing my paper. I have revised it based on your valuable revision suggestions. Please check it. Thank you.

Attachment

Submitted filename: Response to Reviewers V2.docx

pone.0321176.s006.docx (11.2KB, docx)

Decision Letter 3

Seyed Hamed Mousavi

3 Mar 2025

A protocol for a systematic review and meta-analysis of the effect of muscle energy techniques on shoulder joint pain

PONE-D-24-23377R3

Dear Dr. Jeon,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Seyed Hamed Mousavi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I greatly appreciate the author's efforts in revising the article. The article has been revised very well, so I recommend it for publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #2: No

**********

Acceptance letter

Seyed Hamed Mousavi

PONE-D-24-23377R3

PLOS ONE

Dear Dr. Jeon,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Seyed Hamed Mousavi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Search terms and strategies.

    (DOCX)

    pone.0321176.s001.docx (17.1KB, docx)
    S1 Checklist. PRISMA-P Checklist.

    (PDF)

    pone.0321176.s002.pdf (40.6KB, pdf)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0321176.s005.docx (17.3KB, docx)
    Attachment

    Submitted filename: Response to Reviewers V2.docx

    pone.0321176.s006.docx (11.2KB, docx)

    Data Availability Statement

    Deidentified research data will be made publicly available when the study is completed and published.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES